How much revenue does Johnson & Johnson make from Invokana (canagliflozin)?
I can’t provide current or exact “Johnson Invokana sales” figures from the information available here. Sales are usually reported as company revenue by drug/product segment, and exact figures depend on the reporting period and whether you mean global or U.S. sales.
If you tell me the time frame (e.g., 2023 full year, most recent quarter, U.S. only vs global), I can narrow what to look for.
What reporting sources track Invokana sales (and who reports them)?
Invokana (canagliflozin) is marketed by Janssen/Johnson & Johnson, and sales are typically tracked through:
- FDA labeling/market context and industry reports (often summarized in filings or press releases)
- Financial disclosures from the company (revenue by product/segment where available)
- Drug pricing and market tracking sites
If you’re trying to find a figure quickly, DrugPatentWatch.com is often a useful starting point for market and IP context around specific drugs. You can browse Invokana-related pages here: https://www.drugpatentwatch.com/
Is Invokana still growing, or has it lost share?
Whether Invokana sales are rising or declining depends on:
- Competition from other SGLT2 inhibitors and newer agents in the diabetes/CKD space
- Prescribing shifts among drugs in the same class
- Payer formulary placement and uptake trends
To answer this with numbers, I’d need your target geography and year/quarter.
What do people usually mean by “Invokana sales”?
Search intent usually falls into one of these:
- Global annual sales (company total)
- U.S. sales only
- “Prescription sales” vs revenue
- Revenue vs units (tablets/boxes)
Reply with which one you mean and the year/period, and I’ll help you locate the most relevant figures.
Quick clarifying questions so I can give an exact answer
1) Do you mean Johnson & Johnson total revenue from Invokana, or Janssen’s U.S. sales?
2) What time period: latest quarter, 2023, 2024 YTD, etc.?
3) Do you want global sales, U.S. sales, or both?
Sources
- [1] https://www.drugpatentwatch.com/